In addition, embryonic treatment with a synthetic inhibitor of Dual specificity Tyrosine(Y) Regulated Kinase 1A (Dyrk1A) prevents postnatal learning defects in the Ts1Cje model of DS [36]. The gene discussed is DYRK1A; the disease is Dravet syndrome.